Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

NCT07317115 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity (Disorder)
Obesity & Overweight
Type 2 Diabetes (T2DM)

Interventions

DEVICE: Magnet System
DRUG: Semaglutide

Sponsor

GT Metabolic Solutions, Inc.